Alec­tor cuts 11% of work­force as it dou­bles down on late-stage neu­ro pro­grams part­nered with GSK, Ab­b­Vie

A month af­ter re­veal­ing plans to con­cen­trate on its late-stage im­muno-neu­rol­o­gy pipeline, Alec­tor is trim­ming its head­count by 11%.

The lay­offs will im­pact around 30 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.